The course of PAI-1 levels in BMT recipients with hyperbilirubinemia. PAI-1 levels (mean ± SD) were elevated significantly (**P < .01) in patients with (▪) VOD (n = 7) as compared with patients with (▴) GVHD (n = 7) or (▾) other liver damage (n = 17)